PuSH - Publication Server of Helmholtz Zentrum München

Grandoch, M.* ; Flögel, U.* ; Virtue, S.* ; Maier, J.K.* ; Jelenik, T.* ; Kohlmorgen, C.* ; Feldmann, K.* ; Ostendorf, Y.* ; Castañeda, T.R.* ; Zhou, Z.* ; Yamaguchi, Y.* ; Nascimento, E.B.M.* ; Sunkari, V.G.* ; Goy, C.* ; Kinzig, M.* ; Sörgel, F.* ; Bollyky, P.L.* ; Schrauwen, P.* ; Al-Hasani, H.* ; Roden, M.* ; Keipert, S. ; Vidal-Puig, A.* ; Jastroch, M. ; Haendeler, J.* ; Fischer, J.W.*

4-Methylumbelliferone improves the thermogenic capacity of brown adipose tissue.

Nat. Metab. 1, 546-559 (2019)
Postprint DOI PMC
Open Access Green
Therapeutic increase of brown adipose tissue (BAT) thermogenesis is of great interest as BAT activation counteracts obesity and insulin resistance. Hyaluronan (HA) is a glycosaminoglycan, found in the extracellular matrix, which is synthesized by HA synthases (Has1/Has2/Has3) from sugar precursors and accumulates in diabetic conditions. Its synthesis can be inhibited by the small molecule 4-methylumbelliferone (4-MU). Here, we show that the inhibition of HA-synthesis by 4-MU or genetic deletion of Has2/Has3 improves BAT`s thermogenic capacity, reduces body weight gain, and improves glucose homeostasis independently from adrenergic stimulation in mice on diabetogenic diet, as shown by a magnetic resonance T2 mapping approach. Inhibition of HA synthesis increases glycolysis, BAT respiration and uncoupling protein 1 expression. In addition, we show that 4-MU increases BAT capacity without inducing chronic stimulation and propose that 4-MU, a clinically approved prescription-free drug, could be repurposed to treat obesity and diabetes.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
0.000
0.000
13
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Language english
Publication Year 2019
HGF-reported in Year 2019
ISSN (print) / ISBN 2522-5812
e-ISSN 2522-5812
Quellenangaben Volume: 1, Issue: 5, Pages: 546-559 Article Number: , Supplement: ,
Publisher Springer
Publishing Place London
Reviewing status Peer reviewed
POF-Topic(s) 90000 - German Center for Diabetes Research
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-501900-221
PubMed ID 31602424
Erfassungsdatum 2019-10-16